top of page

Why Emocog

We create technology that helps sustain brain health

Dementia affects about 10% of the senior population and progresses over a decade. The stage of memory decline before dementia is called Mild Cognitive Impairment (MCI) and progresses overhalf a decade. The prevalence rate is about 25%.

Emocog develops solutions for each stage of dementia, including Cogthera, a cognitive improving digital therapeutics for MCI.

Research

Technology based on world-class scientific results

The results of 20 years of research was published in 5 leading *SCI-indexed journals on brain disease.

*Science Citation Index (SCI): renowned journals carefully selected based on strict criteria among science and technology journals

Solution 1

Emocog builds an ecosystem to care for the entire journey from screening, diagnosis and treatment of dementia.

To overcome the physical constraints of not being able to care for every patient every day, we propose innovative solutions utilizing digital technology.

*Digital treatments and medical applications(DiGA) are virtual medical products that are available as apps for mobile devices or as browser applications. Cogthera DE can quickly enter the market and receive very high insurance rates through these process.

Emocog’s Digital Dementia Solutions

LAUNCH

DATA COLLECTION
& ANALYSIS

DETAILED
DESIGN

PROTOTYPE
& TEST

CONCEPT
DEVELOPMENT

DEFINE
THE BRIEF

MemoryPick    Mobile Cognitive Assessment Service to Screen for Dementia Risk

LAUNCH

PRODUCT
APPROVAL

CLINICAL
EVALUATION

PERFORMANCE
TEST

DETAILED
DESIGN

PROTOTYPE
& TEST

PROOF OF
CONCEPT

CONCEPT
DEVELOPMENT

DEFINE
THE BRIEF

Cogthera KR    Digital Therapeutics for MCI

LAUNCH

PRODUCT
APPROVAL

CLINICAL
EVALUATION

DEVELOPMENT
& PROGRAMING

CONCEPTION

REQUIREMENT
ANALYSIS

(DiGA* fast track process in Germany)

Cogthera DE    German-optimized Digital Therapeutics for MCI

LAUNCH

DATA COLLECTION
& ANALYSIS

DETAILED
DESIGN

PROTOTYPE
& TEST

CONCEPT
DEVELOPMENT

DEFINE
THE BRIEF

PDT    Parkinson’s Disease Diagnostic Assistant Software

LAUNCH

DATA COLLECTION
& ANALYSIS

DETAILED
DESIGN

PROTOTYPE
& TEST

CONCEPT
DEVELOPMENT

DEFINE
THE BRIEF

AlzVoice    Memory and Attention Assessment Service based on Verbal Conversation

It is a responsive web-based online test that can be performed on various devices and operating systems through a QR or a URL.

The test takes only about 5 minutes, providing comfortable and easy-to-use content based on simple words and shapes.

Improve the accuracy of the results through large-scale compliance data by accounting for differences in cognitive function based on age, education, gender, etc.

MemoryPick

MemoryPick is a digital screening tool that helps users detect early signs of cognitive decline. It evaluates memory and executive function, which are the first cognitive areas to decline due to dementia, as well as subjective cognitive decline and depression.

At the end of the test, it shows an instant results report representing the user’s brain health. Based on the results, it recommends memory strategies to help daily life and lifestyle habits to keep the brain healthy.

Mobile cognitive assessment service to help screen for dementia risk

1

Conversation-based interface using vocal cues, made for the convenience of patients with early cognitive decline.